Insulin deficiency and resistance are considered the central issues in type 2 diabetes, with novel pharmacological agents potentially addressing a dozen disease-specific targets.36 However, insulin levels are often adequate in OH. This evidence concerns the gene INS and type 2 diabetes mellitus.